Overview

A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder

Status:
Recruiting

Trial end date:
2024-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare ActiveMatrix® to standard of care corticosteroid injection in the treatment of adhesive capsulitis of the shoulder (frozen shoulder).

Phase:

Phase 4

Details

Lead Sponsor:

The University of Texas Health Science Center, Houston

Collaborator:

Skye Biologics, Inc.

Treatments:

Lidocaine
Triamcinolone